Abstract
Introduction:
We aimed to assess the effect of spray cryotherapy (LNSC) on immune-microenvironment of esophageal cancer (EC).
Methods:
Matched retrospective case-control study of locally advanced EC patients who underwent LNSC plus chemoradiation (CRYOCHEMOXRT) versus chemoradiation alone (CHEMOXRT). A microarray was generated from pre- and post-treatment tissue blocks and subjected to multiplex immunofluorescence.
Results:
Intra-tumor T lymphocytes (IT-TILs) and cytotoxic T-cells increased more frequently with CRYOCHEMOXRT versus CHEMOXRT. Mean survival was 1402 versus 686 days with and without 5× increase in IT-TILs.
Discussion:
LNSC may stimulate an anti-tumor immune response that enhances effectiveness of neoadjuvant CRT in locally advanced EC.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
